Meet Kelly and learn about her journey with a rare and aggressive form of brain cancer.
ABF Dark Blue Header
Dear Friend,

For people with incurable brain diseases, it can feel like there is no future. Kelly Rodenberg is one of those people.

In October 2018, Kelly left a massage appointment thinking she’d pinched a nerve in her neck. But later that night, she was woken up from a deep sleep by lightning bolts running through her left hand. Over the next few days, she realized she had lost feeling in her left hand and knew something was seriously wrong.

An MRI confirmed a golf-ball-sized tumor above Kelly’s right ear, which was affecting the left side of her body. The tumor was a glioblastoma, a rare and aggressive type of cancer that occurs in the brain and spinal cord. “You sit up in your chair a little bit straighter when the neurologist starts talking about your life in months versus years,” Kelly says.

Kelly had major brain surgery to remove the tumor and underwent chemotherapy and radiation. Although Kelly’s treatment was successful, there is no cure for glioblastoma, and she’ll battle this disease for the rest of her life.

Donate today for a future without brain disease >>

Having survived more than two years after diagnosis already puts Kelly in a select group, but the odds aren’t in her favor. Only 25% of glioblastoma patients survive more than one year, and only 5% of patients survive more than five years.

No one should have to live life knowing the odds are against them. Make a gift today to give someone like Kelly a chance to plan for their future.

With appreciation,
Emily Christian
Director of Advancement & External Relations

P.S. Your donation can help the world’s leading neurology researchers discover a cure for diseases like glioblastoma. Will you donate today to give someone like Kelly a future without brain disease?

Follow Us on Facebook Follow Us on Twitter Follow Us on Instagram
201 Chicago Ave, Minneapolis, MN 55415 | Tel: 1-866-770-7570
American Brain Foundation © 2023 All rights reserved.